Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet regimen for treating HIV infection. This medication combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the the viral ability to copy within the body, significantly reducing the viral burden. For many in